08/13/2025
11:49 AM | Capital International Investors (Filed by)
Royalty Pharma (Subject)
| Form SCHEDULE 13G | |
08/08/2025
3:58 PM | Coyne Terrance P. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2025
4:00 PM | Legorreta Pablo G. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2025
3:52 PM | Royalty Pharma (Issuer)
Urist Marshall (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2025
8:30 AM | Royalty Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2025
6:10 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2025
10:56 AM | MORGAN STANLEY (Filed by)
Royalty Pharma (Subject)
| Form SCHEDULE 13G/A | |
07/31/2025
7:42 PM | Ho Carole (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2025
7:45 PM | Royalty Pharma (Issuer)
WEATHERMAN ELIZABETH H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2025
3:23 PM | Royalty Pharma (Issuer)
WEATHERMAN ELIZABETH H (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/17/2025
7:40 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for RPRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Royalty Pharma and its competitors with MarketBeat's FREE daily newsletter. |
06/30/2025
4:06 PM | Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:05 PM | Legorreta Pablo G. (Filed by)
Royalty Pharma (Subject)
| Form SCHEDULE 13D | |
05/20/2025
3:49 PM | Legorreta Pablo G. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
3:51 PM | Lloyd George W. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
3:52 PM | Coyne Terrance P. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:22 PM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
4:41 PM | Engelbert Catherine M. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
4:04 PM | Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
4:06 PM | Coric Vlad (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
4:07 PM | DESOUZA ERROL B (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
4:08 PM | Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
4:09 PM | HODGSON DAVID C (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
4:11 PM | LOVE TED W (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
4:12 PM | Norden Gregory (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
9:39 AM | Royalty Pharma (Subject)
| Form SCHEDULE 13G/A | |
05/09/2025
4:07 PM | Royalty Pharma (Issuer)
Urist Marshall (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:10 PM | Coyne Terrance P. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:14 PM | Hite Christopher (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:15 PM | Lloyd George W. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:18 PM | Legorreta Pablo G. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
8:14 AM | Royalty Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2025
6:31 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2025
5:19 PM | Royalty Pharma (Subject)
Severgnini Achille G. (Filed by)
| Form SCHEDULE 13D/A | |
04/21/2025
4:43 PM | Coric Vlad (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:40 PM | Coric Vlad (Reporting)
Royalty Pharma (Issuer)
| Form 3/A | |
04/21/2025
4:18 PM | Royalty Pharma (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/11/2025
8:15 AM | Royalty Pharma (Filer)
| Form DEFA14A | |
04/11/2025
7:45 AM | Royalty Pharma (Filer)
| Form DEFM14A | |
04/11/2025
7:50 AM | Royalty Pharma (Filer)
| Form ARS | |
04/11/2025
7:53 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The stealth altcoin the financial world is underestimating (Ad) This DeFi project could soar next
When altcoin season fully kicks in—which the data suggests is happening RIGHT NOW—this project is poised to see massive moves....
The smart money is already positioning. Discover the protocol that's quietly replacing traditional finance. |
04/10/2025
3:17 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
04/10/2025
3:06 PM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
4:45 PM | Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
4:46 PM | Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
4:25 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
02/21/2025
3:30 PM | Royalty Pharma (Subject)
Severgnini Achille G. (Filed by)
| Form SCHEDULE 13D/A | |
02/13/2025
5:03 AM | Royalty Pharma (Filer)
| Form PREM14A | |
02/12/2025
8:30 AM | FMR LLC (Filed by)
Royalty Pharma (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
6:38 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2025
4:12 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
01/16/2025
4:15 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
01/15/2025
4:04 PM | Royalty Pharma (Subject)
| Form 425 | |
01/13/2025
7:40 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
7:42 AM | Royalty Pharma (Filer)
| Form DEFA14A | |
01/10/2025
4:21 PM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
4:26 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
01/10/2025
6:47 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
3:05 PM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
2:15 PM | MORGAN STANLEY (Filed by)
Royalty Pharma (Subject)
| Form SC 13G/A | |
11/06/2024
8:24 AM | Royalty Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
6:35 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
4:07 PM | Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:08 PM | Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
7:39 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access